This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of deuterated drug molecules. Its boronic acid group makes it a valuable reagent in Suzuki-Miyaura cross-coupling reactions, which are widely employed to create carbon-carbon bonds in the production of complex organic molecules. The deuterium atoms (d8) in the pyrrolidine ring enhance the metabolic stability of the resulting compounds, making it useful for the development of deuterated drugs with improved pharmacokinetic properties. Additionally, it serves as a building block in the design of potential therapeutic agents, especially in the fields of oncology and neurology, where precise molecular modifications are critical for efficacy and safety.